DrugPatentWatch Database Preview
Spil Company Profile
Email this page to a colleague
What is the competitive landscape for SPIL, and when can generic versions of SPIL drugs launch?
SPIL has three approved drugs.
There are two US patents protecting SPIL drugs.
There are eight patent family members on SPIL drugs in seven countries and six supplementary protection certificates in three countries.
Summary for Spil
| International Patents: | 8 |
| US Patents: | 2 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Spil
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spil | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 210838-003 | Apr 16, 2019 | AB2 | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-003 | Jan 26, 2018 | RX | Yes | No | 9,504,655 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-001 | Jan 26, 2018 | RX | Yes | No | 9,700,530 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-002 | Jan 26, 2018 | RX | Yes | No | 9,700,530 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Spil | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 210838-002 | Apr 16, 2019 | AB2 | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-004 | Jan 26, 2018 | RX | Yes | Yes | 9,504,655 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-003 | Jan 26, 2018 | RX | Yes | No | 9,700,530 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Spil Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2017523164 | ⤷ Try it Free |
| Brazil | 112017000468 | ⤷ Try it Free |
| European Patent Office | 3166599 | ⤷ Try it Free |
| World Intellectual Property Organization (WIPO) | 2016005934 | ⤷ Try it Free |
| Japan | 6626492 | ⤷ Try it Free |
| Australia | 2015287299 | ⤷ Try it Free |
| Canada | 2954474 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Spil Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1411900 | 2011C/016 | Belgium | ⤷ Try it Free | PRODUCT NAME: NAPROXENE ET ESOMEPRAZOLE (SOUS LA FORME D'ESOMEPRAZOLE MAGNESIUM TRIHYDRATE); AUTHORISATION NUMBER AND DATE: BE382505 20101214 |
| 1411900 | 2011/016 | Ireland | ⤷ Try it Free | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105 |
| 0984957 | SPC/GB11/013 | United Kingdom | ⤷ Try it Free | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
| 0124495 | SPC/GB01/006 | United Kingdom | ⤷ Try it Free | PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727 |
| 1411900 | SPC/GB11/015 | United Kingdom | ⤷ Try it Free | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
| 0984957 | 2012/048 | Ireland | ⤷ Try it Free | PRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
